Cancer germline antigens and tumor-agnostic CD8+ T cell evasion

Dian Kortleve1, Rui M L Coelho1, Dora Hammerl1

  • 1Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands.

Trends in Immunology
|April 13, 2022
PubMed

Insights

Cancer germline antigens (CGAs) re-expressed in tumors may help cancer cells evade immune detection by CD8+ T cells. This study explores CGAs

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Cancer germline antigens (CGAs) are normally confined to immune-privileged germline tissues but are re-expressed in tumors, potentially promoting oncogenesis.
  • Tumors utilize mechanisms similar to germline tissues to evade immune surveillance, particularly from CD8+ T cells.
  • The role of CGAs in tumor immune evasion remains largely unexplored.

Purpose of the Study:

  • To investigate the hypothesis that CGAs contribute to tumor escape from CD8+ T cell-mediated immunosurveillance.
  • To explore the association between CGAs and known CD8+ T cell evasion mechanisms in various cancer types.

Main Methods:

  • Assessed the co-expression patterns of eight cancer germline antigen transcripts with transcripts of adhesion molecules, endothelial cells, and Wnt pathway components in multiple tumor types.
  • Analyzed the co-presence or co-absence of CGAs with CD8+ T cells in tumor tissues.

Main Results:

  • Demonstrated the co-occurrence of gene transcripts for eight CGAs with those involved in CD8+ T cell evasion mechanisms.
  • Observed associations between CGAs and factors facilitating tumor immune escape, such as adhesion molecules and the Wnt pathway.

Conclusions:

  • CGAs represent a novel factor associated with CD8+ T cell evasion in tumors.
  • The proposed concept of CGAs contributing to tumor immune evasion may offer new avenues for immunotherapeutic interventions.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
691
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
3.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
6.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
535